What are the side effects of neratinib/neratinib?

Neratinib is a kinase inhibitor used as a single agent for the long-term adjuvant treatment of adult patients with early-stage HER2-positive breast cancer receiving trastuzumab-based adjuvant therapy. Neratinib, in combination with capecitabine, is indicated for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-her 2-based regimens in the metastatic setting.

Neratinib/NeratinibDiarrhea (95%), Nausea ( span>43%), Abdominal pain (36%), Fatigue (27%), vomiting (26%), rash (18%), stomatitis (14%) , Decreased appetite (12%), Muscle spasm (11%), Indigestion ( span>10%), Elevated alanine aminotransferase (9%), Nail disease (8%), Elevated aspartate aminotransferase (7%), Dry skin (6%), Abdominal distension (5 %), Urinary tract infection (5%), Nistaxis (5%), Dehydration (4%), dry mouth (3%), skin cracks (2%), etc. Neratinib immediate-release oral film-coated tablets contain 40mg of neratinib, equivalent to 48.31mg of neratinib maleate. Neratinib is a member of the 4-anilinoquinoline class of protein kinase inhibitors. The molecular formula of neratinib maleate isC30H 29Central necrosis6O 3C4H 4O 4The molecular weight is673.11Daltons. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.